Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-113516
Filing Date
2024-11-01
Accepted
2024-11-01 16:30:16
Documents
2
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2427268-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2427268-1_3seq1.xml 3 1600
2 EXHIBIT 24.1 tm2427268d1_ex24-1.htm EX-24.1 7499
  Complete submission text file 0001104659-24-113516.txt   10790
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459
Business Address
Cheng Sohanya Roshan (Reporting) CIK: 0001865796 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 241419455